Overall rank by patents
#32,741
Across all tracked assignees
USPTO PatentsView assignee record - 8 granted patents across 12 technology areas, active 2019–2024. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C10L (FUELS NOT OTHERWISE PROVIDED FOR; NATURAL GAS; SYNTHETIC NATURAL GAS OBTAINED BY PROCESSES NOT COVERED BY SUBCLASSES C10G OR C10K; LIQUIFIED PETROLEUM GAS; USE OF ADDITIVES TO FUELS OR FIRES; FIRE-LIG).
The verdict
Omnis holds 8 US patents across 12 technology areas, rank #32,741 of 50,000 tracked assignees.
Omnis Advanced Technologies, Llc has been granted 8 US utility patents between 2019 and 2024, placing Omnis Advanced Technologies, Llc at rank #32,741 across all assignees tracked by PlainPatent. This portfolio spans 12 distinct Cooperative Patent Classification (CPC) subclasses, averaging 19.4 claims per patent with primary concentration in C10L (FUELS NOT OTHERWISE PROVIDED FOR; NATURAL GAS; SYNTHETIC NATURAL GAS OBTAINED BY PROCESSES NOT COVERED BY SUBCLASSES C10G OR C10K; LIQUIFIED PETROLEUM GAS; USE OF ADDITIVES TO FUELS OR FIRES; FIRE-LIG). As a US Corporation, Omnis Advanced Technologies, Llc is one of the more focused assignees in the PatentsView dataset. By volume, Omnis sits between Olive Healthcare Inc. (8 patents, rank #32,737) and Onduline Sa (8 patents, rank #32,745) - the closest US assignees by grant volume. The composite Innovation Score of 42.6/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 7 grants, compared with 1 in the 2015–2019 window, a +600% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Omnis Advanced Technologies, Llc's 19.4 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 12 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Omnis Advanced Technologies, Llc against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Olive Healthcare Inc.
8 patents
Oliver Technologies, Inc.
8 patents
Olympia International, Inc.
8 patents
Omnicharge, Inc.
8 patents
OnBoard Security, Inc.
8 patents
Oncam Global, Inc.
8 patents
OncoSec Medical Incorporated
8 patents
Onduline SA
8 patents
Omnis Advanced Technologies, LLC
8 patents
What this shows Omnis holds 8 patents at rank #32,741, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #32,741 in granted patent volume.
Other assignees with the most granted patents in Omnis's primary technology class.
Omnis's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
43 Top 30% higher than 70% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2019 | 1 | 12.5% |
| 2020 | 2 | 25.0% |
| 2022 | 2 | 25.0% |
| 2023 | 1 | 12.5% |
| 2024 | 2 | 25.0% |
Top 12 of 12 technology areas
Overall rank by patents
#32,741
Across all tracked assignees
42.6 out of 100
How to use this portfolio
Omnis's 8 grants land it in the top 30% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.